Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- Check4 days agoChange DetectedThe new screenshot shows minor layout adjustments on the Record History page, with no changes to study data, statuses, or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedNew 2025-10-27 update adds the Study Status entry to the record history; the total versions now show 16, and an older entry from 2025-06-03 was removed.SummaryDifference0.4%

- Check33 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check40 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check54 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No other core content, pricing, or availability changes were detected.SummaryDifference0.7%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.